EMPOWER-1 and EMPOWER-2 Phase 2 clinical trials did not meet their primary endpoint Emraclidine was well-tolerated with an adverse event profile consistent with ...
"We are excited to provide an updated assessment of objective response to dordaviprone previously reported in the blinded independent central review (BICR) cohort 1 in recurrent H3 K27M-mutant diffuse ...
Corbus Pharmaceuticals still shows promise, with CRB-701 and CRB-601 advancing in clinical trials. Read why CRBP stock is ...
Nine-month Results Remain On Track for Net ProfitAd Hoc Announcement Pursuant to Art. 53 LRGeneva, Switzerland, November 11, 2024-Addex ...
Six years after the deadly Camp Fire tore through Butte County and nearly destroyed the town of Paradise. Itwas the deadliest ...
Celebrities and influencers have been endorsing the scan all over social media, but it comes with a wild price tag.
Liyanage Amarakeerthi Professor of Sinhala, University of Peradeniya (Keynote speech delivered at the International ...
The northern vote should be examined against the backdrop of expulsion of the entire Muslim population from that province in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback